abstract |
This invention provides novel dihydropyridine derivatives of the formula I n nhaving protein tyrosine kinase inhibitory activity, to process for the manufacture thereof and to the use thereof for the treatment of c-Met-mediated diseases or c-Met-mediated conditions. |